-
Stock markets track Wall St down with Nvidia, US jobs in view
-
Malaysia to appeal to CAS after damning FIFA report on forgery scandal
-
TotalEnergies accused of Mozambique war crimes 'complicity'
-
England quick Wood back bowling after injury scare
-
US lawmakers set for explosive vote on Epstein files
-
Gianfranco Rosi: the slow documentary maker in a frantic world
-
P.Priime, Nigeria's young leading Afrobeats producer
-
Merz, Macron to push for European digital 'sovereignty'
-
Trump hosts Saudi prince for first time since Khashoggi killing
-
Tonga's Katoa out of NRL season after brain surgery
-
Japan warns citizens in China over safety amid Taiwan row
-
In Somalia, a shaky front line barely holds back the 'dogs of war'
-
Shares in 'Baby Shark' studio jump on market debut
-
Thunder breeze past Pelicans, Pistons overpower Pacers
-
Grieving Cowboys remember Kneeland, defeat Raiders
-
Loaf behind bars: Aussie inmate says Vegemite a human right
-
In film's second act, 'Wicked' goes beyond Broadway musical
-
Asian markets track Wall St down with Nvidia, US jobs in view
-
Scott Boland: the best 'spare' fast bowler around
-
Fire and Ashes: England bank on fast bowling barrage in Australia
-
North Korea says Seoul-US sub deal will trigger 'nuclear domino' effect
-
Education for girls hit hard by India's drying wells
-
Haitian gangs getting rich off murky market for baby eels
-
Trump says will talk to Venezuela's Maduro, 'OK' with US strikes on Mexico
-
Oscar Piastri wins Australia's top sports honour
-
'Severely restricted': Russia's Saint Petersburg faces cultural crackdown
-
Polish PM denounces 'sabotage' of railway supply line to Ukraine
-
UK toughens asylum system with radical overhaul
-
Carney's Liberals pass budget, avoiding snap Canada election
-
LeBron back in training, edges closer to Lakers return
-
Climate talks run into night as COP30 hosts seek breakthrough
-
Germany and Netherlands lock up World Cup spots in style
-
Germany's Woltemade hopes for 2026 World Cup spot after scoring again
-
Germany 'send message' with Slovakia rout to reach 2026 World Cup
-
Trump unveils fast-track visas for World Cup ticket holders
-
Netherlands qualify for World Cup, Poland in play-offs
-
Germany crush Slovakia to qualify for 2026 World Cup
-
Stocks gloomy on earnings and tech jitters, US rate worries
-
'In it to win it': Australia doubles down on climate hosting bid
-
Former NFL star Brown could face 30 yrs jail for shooting case: prosecutor
-
Fate of Canada government hinges on tight budget vote
-
New research measures how much plastic is lethal for marine life
-
Mbappe, PSG face off in multi-million lawsuit
-
EU defends carbon tax as ministers take over COP30 negotiations
-
McCartney to release silent AI protest song
-
Stocks tepid on uncertainty over earnings, tech rally, US rates
-
Louvre shuts gallery over ceiling safety fears
-
'Stranded, stressed' giraffes in Kenya relocated as habitats encroached
-
US Supreme Court to hear migrant asylum claim case
-
Western aid cuts could cause 22.6 million deaths, researchers say
Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
F.AbuShamala--SF-PST